Patricia Ogilvie graduated in medicine at the University of Würzburg, Germany with an MD thesis in clinical biochemistry. After her residency in dermatology at universities in Germany and Switzerland, she became a postdoctoral research fellow of the German Research Foundation and spent several years in the field of immunology and cell signaling at international research institutions under the mentoring of Nobel Laureate Renato Dulbecco(ƚ). Dr. Ogilvie received the German board certification for dermatology and allergology in 2003. In 2004, she founded Skinconcept, 2 private clinics for dermatology, laser medicine and clinical research in Munich. Dr. Ogilvie is Director at Large of the International Neurotoxins Association, member of the “Reverse Aging Scientific Advisory Board” of DIOR research, an international conference director and speaker, Co-founder of the Science of Aging Conference, scientific advisor and trainer for botulinum toxin and injectable fillers, and a principal investigator in clinical trials, She has authored over 80 scientific papers in the field of biochemistry, immunology, clinical dermatology and aesthetic medicine. Her research focus in aesthetic medicine is neuromodulators, where she participated in numerous clinical trials, novel injectable fillers, and attractiveness research.